問卷
Log In
繁中 EN
TPIDB
TPIDB Outstanding PI
TPIDB > Search Result

Search Result

篩選

Developmental Phase

  • Phase I

  • Phase I/II

  • Phase II

  • Phase II/III

  • Phase III

  • Phase IV

  • Others

Trial Status

  • Not yet recruiting

  • Active

  • Completed

Recruitment Status

  • Not yet recruiting

  • Recruiting

  • Completed

  • Terminated

  • Stop recruiting

  • Suspended

  • Study ended

Trial scale

  • Multi-Regional Multi-Center

  • Taiwan Multiple Center

  • Taiwan Single Center

The expected start time interval of the test

-

Trial Applicant

  • Hospital/Foundation

  • Pharmaceutical/Biopharmaceutical company

  • Contract Research Organization

Important Roles

  • Asia Regional PI

  • Taiwan National PI

  • Chairman/Global PI

  • Steering Committee

  • Advisory board

  • None

Audit by Sponsors/CRO

  • Sponsors

  • CRO

  • None

Investigator-initiated trial(IIT)

  • Yes

Filters

List

5239Cases

2019-11-01 - 2021-12-31

IIT

Phase I

A RANDOMIZED, PLACEBO-CONTROLLED, OBSERVER-BLINDED STUDY, TO EVALUATE SAFETY, TOLERABILITY, PHARMACOKINETICS AND PHARMACODYNAMICS OF RO7239958 IN HEALTHY VOLUNTEERS AND PATIENTS WITH CHRONIC HEPATITIS B VIRUS INFECTION

  • Condition/Disease

    Hepatitis B Virus Infection

  • Test Drug

    RO7239958

Participate Sites
1Sites

Terminated1Sites

2019-03-01 - 2021-02-28

Phase I

An Openlabel, Pilot Pharmacokinetic Study to Determine the Bioavailability, Safety, and Tolerability of a Single Dose of Oradoxel in Metastatic Prostate Cancer Patients Treated With Intravenou s Docetaxel

  • Condition/Disease

    Metastatic Prostate Cancer

  • Test Drug

    Oradoxel (Docetaxel + HM30181)

Participate Sites
3Sites

Recruiting3Sites

2020-06-16 - 2023-12-31

Phase III

A Randomized, Double-Blind, Phase III Study Comparing FTD/TPI Therapy Versus Placebo in Patients Who Are Positive for Blood Circulating Tumor DNA After Curative Resection of Colorectal Cancer

  • Condition/Disease

    Curative Resection of colorectal cancer

  • Test Drug

    LONSURF

Participate Sites
1Sites

Recruiting1Sites

2015-07-08 - 2019-06-30

IIT

Others

  • Condition/Disease

  • Test Drug

Participate Sites
1Sites

2016-05-30 - 2020-04-30

IIT

Phase III

  • Condition/Disease

  • Test Drug

Participate Sites
1Sites

2015-03-01 - 2019-04-30

IIT

Phase III

  • Condition/Disease

  • Test Drug

Participate Sites
1Sites

-

IIT

Phase II

  • Condition/Disease

  • Test Drug

Participate Sites
1Sites

周元華
Taipei Veterans General Hospital

未分科

2014-02-21 - 2019-12-31

IIT

Others

  • Condition/Disease

  • Test Drug

Participate Sites
1Sites

-

Others

  • Condition/Disease

  • Test Drug

Participate Sites
0Sites

1 520 521 522 523 524
聯絡我們

台灣臨床試驗主持人資料庫 TPIDB

All Contents Copyright 2020 台灣臨床試驗主持人資料庫TPIDB